Skip to content
★ Sign in to follow
AC

Anthony C. Celeste

Executive
Sucampo Pharmaceuticals, Inc.
Total declarations
16
Company
1
▲ Purchases (3 ops.)
€18k
▼ Sales (5 ops.)
€1.1M

Latest filing published 18 Mar 2015 for Sucampo Pharmaceuticals, Inc., €20k.

Insider track record

Disclosed buys
3
Disclosed sells
5
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Anthony C. Celeste: trading record in brief

All filings by Anthony C. Celeste on record concern Sucampo Pharmaceuticals, Inc. In total, 16 filings cover trades dated from 2 September 2009 to 11 March 2015.

In open-market terms, that means 3 purchases worth €18k on one side and 5 sales worth €1.1M on the other. Netting one side against the other leaves €1.1M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 8 option exercises. In 2015 alone, the filings show no purchases and 5 sales.

The median purchase comes to €4,910.

The newest entry dates from 18 March 2015: an option exercise of €20k, in Sucampo Pharmaceuticals, Inc. The most recent open-market purchase was published on 8 September 2009, 6,271 days ago. The median gap between a trade and its publication by SEC (Form 4) is 7 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Anthony C. Celeste

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations